The Sick Dragon: Changes are Required in China’s Rural Health Sector

China has made good progress in universal health coverage (UHC) over the past decade, with a significant increase in health care utilization especially for the poor. However, a number of challenges still exist, including how to close the gaps in service coverage between people settled in urban and rural areas. Though substantial results have been achieved by implementation plans, additional efforts are required for the rural health sector

Pietro_picture-150x150

by Pietro Dionisio

Degree in Political Science, International Relations

Cesare Alfieri School, University of Florence, Italy

The Sick Dragon: Changes are Required in China’s Rural Health Sector

 

China is a middle-income developing country home to 1,4 billion people, over 46% of whom living in rural areas.

Since 1978, China has experienced over three decades of rapid economic growth, with annual growth rates of over 9%. Despite this “economic miracle”, the country has witnessed a  broadening urban-rural inequality, as revealed across a range of indicators such as income, education, medical care, provision of infrastructure, and social insurance.

Available data also show that an imbalance in health care resource allocation between urban and rural areas still persists.

Aiming to bridge the gaps and  build a more equitable society, the Chinese Government has implemented several policies:

  • The “China Rural Health Project” was implemented in 2008 as a three-pronged plan to ameliorate rural health financing, improve on service delivery quality, efficiency and cost control, and earmark additional public health utilities. Since its implementation, the project was enforced in 40 counties (60% of which ranking as national poverty counties). Up to now, also thanks to a sustainable insurance scheme system for rural health, important results have been achieved. Almost 2,300 village clinics were built or refurbished and 180,728 work forces went on training courses.
  • A performance-based evaluation system was also introduced in primary health care facilities at a time when government subsidies to facilities and staff incomes depend on the assessment of their performances.
  • Meanwhile, through the “Essential Public Health Services” (EPHS), the Government provides 35 yuan per capita to finance basic health service packages covering 42 services.
  • Additionally, the “New Rural Cooperative Medical Scheme” (NRCMS) has been expanded to cover 802 million people accounting for 99% of the whole rural population. Noticeably, the relevant earmarking increased from 30 yuan per capita in 2003 to 370 yuan per capita in 2013. What’s more, patients are reimbursed as much as 75% of their inpatient expenditures. As a result, the percentage of out-of-pocket expenditures for rural residents has dropped from 73,4% to 49,5%.

Call for Further Measures                    

Despite unquestionable progress, many unsolved issues lie on the table.

Social health insurance schemes still are fragmented, leading to inequitable access and lower financial risk protection (out-of-pocket health expenditure was equal to 76.7% in 2013). This gap needs fixing by a consolidated health insurance system.

Even worse, China has a highly mobile population of nearly 252 million rural inhabitants migrating to urban areas where are they principally employed in health hazard industrial jobs. Should health needs unfortunately occur, they do not qualify for public medical insurance (which grounds on locally based household schemes – Hukou System), since they are scored in counties other than where they work. Relevantly, hypotheses about reforming the Hukou System came out over the last decade, but with no effect up to now.

Not to mention that important gaps in quality of care still persist, equally involving the primary health care and hospital systems.

Taken together, all insights here suggest that, adding to the efforts deployed over the last decade, the Government should streamline performance indicators and quality of care programs coupling with a knowledge sharing system all around the country so as to ameliorate health conditions in urban and rural areas as well.

Furthermore, the development of an educational framework for health workers on a regular basis is highly required since general practitioners, doctors, nurses and public health staffs still lack enough skill.

No doubt that the Dragon is still sick despite the relevant policies and strategies implemented over the last years. More efforts are needed given that, in spite of China’s good performance in achieving UHC, too many inequalities endure across regions, and challenges, such as the worsening of non-communicable-diseases issue, are on stage.

Will the Government be able to address all needs and gaps above ?

Nuovi Obiettivi di Sviluppo Sostenibile: Zoppi Senza Radicali Svolte di “Governance”

L’Agenda  2030 per lo Sviluppo Sostenibile, adottata dalle Nazioni Unite nel settembre 2015, difficilmente centrerà  l’obiettivo “Salute” a meno di svolte radicali dei governi per correggere le disfunzioni che minano l'accesso

    MINOLTA DIGITAL CAMERA

Daniele Dionisio*

Membro, European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases. Responsabile del Progetto Policies for Equitable Access to Health -PEAH

  Nuovi Obiettivi di Sviluppo Sostenibile: Zoppi Senza Radicali Svolte di “Governance”

 

Nel panorama mondiale odierno, lacerato da scollamenti, discordie ed attriti fra le parti, le radici delle iniquità e disuguaglianze nel campo della salute sono iscritte nelle disfunzioni proprie degli ambiti “politici” nazionali e sovranazionali. Tra queste: fiacca coscienza democratica, debole spirito di responsabilità, rigidità istituzionali, carenza di strutture, e spazi ristretti per politiche di salute a sincera difesa dei deboli.

Questo contesto implica che soluzioni non discriminatorie per la salute globale dipendono unicamente dalla volontà politica di esercitare equità, coerenza, coordinamento, collaborazione, trasparenza e responsabilità a livello nazionale e internazionale.

Purtroppo, gli accordi commerciali e le direzioni governative nello scenario  corrente, largamente da parte di Unione Europea e Stati Uniti d’ America, marciano all’opposto convertendo la protezione della proprietà intellettuale in politiche sbilanciate a favore di interessi di monopolio. Il tutto a spese dell’accesso equo alle cure e all’assistenza delle popolazioni a risorse limitate.

E poiché gli incentivi del sistema brevettuale vigente si fondano sui profitti, intesi come ritorni celeri e cospicui nelle tasche degli azionisti, i Paesi a più basso reddito privi di lucrabili mercati farmaceutici risultano oltremodo discriminati.

Tutto questo altro non significa che il fallimento delle attuali politiche per la salute globale, come tristemente rappresentato, giusto ad esempio, dal mal gestito contenimento della recente epidemia di Ebola.

Nel frattempo, la Agenda 2030 per lo Sviluppo Sostenibile è stata adottata lo scorso settembre dalle Nazioni Unite. Centrata su 17 Goals per lo Sviluppo Sostenibile (SDGs), con 169 obiettivi strutturali, l’Agenda vuol essere …un documento programmatico per le popolazioni ed il pianeta nel ventunesimo secolo. Essa stimolerà all’azione nei prossimi 15 anni in settori critici per la costruzione di un mondo più equo e sostenibile per tutti…  

Come evidenziato, …..Nell’Agenda la salute occupa un posto di assoluto rilievo tra gli altri 16 SDGs e include nove obiettivi: tre correlati ai Millennium Development Goals (MDGs), tre a lesioni e patologie non trasmissibili, e tre trasversalmente mirati a copertura sanitaria universale (UHC), accesso ai servizi per la salute sessuale e riproduttiva, riduzione dell’inquinamento ambientale delle acque, dell’aria e del suolo. 

Il Goal salute si embrica con molti degli altri 16 SDGs. Ad esempio, la salute contribuisce (traendone reciproco vantaggio) alla riduzione della povertà, al sollievo dalla fame, al miglioramento della nutrizione, alla sicurezza urbana, all’abbattimento delle disuguaglianze, alla sostenibilità dei consumi, all’accesso ad energia pulita, acqua potabile e igiene pubblica, alla appropriata gestione delle sostanze tossiche, e agli sforzi per il controllo delle mutazioni climatiche e la salvaguardia degli ecosistemi aerei, acquatici e terrestri.   

Cosa possiamo  ragionevolmente  aspettarci  dall’Agenda a fronte degli scenari sopra accennati?

La speranza del facile conseguimento di goals per la salute onnicomprensivi e non discriminatori è difficilmente credibile con il carico di problematiche irrisolte ancora sul tavolo. Come asserito …Conseguire equità in salute non dipende solo da soluzioni tecniche e dal loro finanziamento. Dobbiamo considerare il panorama politico e correggere le disfunzioni della “governance” globale che minano la salute….

Ammettiamolo, i governi dei Paesi ricchi non sembrano oggi pronti ad impegnarsi per la correzione di queste disfunzioni quale occasione propizia per collocare stabilmente la salute pubblica al di sopra degli interessi politici e commerciali.

Conseguentemente, il completo successo dei nuovi SDGs può solo scaturire dalla pressione continua di coalizioni non governative su scala mondiale per indurre i governi a svolte radicali attraverso misure condivise.  Tra l’altro e irrinunciabilmente, queste dovrebbero includere che le istituzioni e organizzazioni leader collaborino di più e meglio con i ministeri per la salute per rafforzare i sistemi nazionali, investire nelle infrastrutture, creare maggiore trasparenza e responsabilità, e dar vita a regole più attente ai bisogni di salute che alle logiche di mercato.

Questo implica che negoziati a porte chiuse devono essere banditi e che modelli partecipativi multi-settoriali devono essere adottati per decisioni gravanti su salute pubblica, crescita, impiego e bilanci nazionali.

 ———————————————————————————–

*Sintesi dell’articolo originale pubblicato in  Intellectual Property Watch September 24, 2015 http://www.ip-watch.org/2015/09/24/un-sdgs-need-u-turn-on-governance-for-health/

 

Breaking News: Link 162

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

medusa

Breaking News: Link 162

 

US, AU and CA try to block WTO LDC drug patent waiver because PhRMA’s not happy enough with the TPP 

Access to affordable generic medicines for world’s poorest countries under threat 

Empty gestures: The EU’s commitments to safeguard access to medicines 

Empty gestures: The EU’s commitments to safeguard access to medicines  

Some KEI Tweets regarding TPP IP Chapter 

Commentary on TPP IP Chapter Leak 

Foundations That Care About Equity Have Been MIA on Global Trade Issues. Why? 

The FDA Could Earn Over $60 Million A Day From Enforcing The Law 

Who Makes This Drug? Disclosing The Identity Of Generic Drug Manufacturers 

Chatham House Report On Antibiotics Gives Evidence For Drug R&D Delinkage 

G7 Health Ministers Propose Incentives For New Antibiotics, Commit Help On Ebola 

WTO Paper Could Spark New Ideas On TRIPS Special Compulsory Licence For Medicines Export 

WIPO And The Sustainable Development Goals – The IP Agency’s Evolution In The UN 

UN Agency: Sustainable Development Requires Altering The World’s Financial System 

Webinar Series – The Building Blocks of Integrated Care  

World will pass crucial 2C global warming limit, experts warn 

COP21 is about the money, not the environment! 

Pre-Paris: What every development professional should know about climate change 

UN agency and French Government urge inclusion of food security in global climate change debate 

From hopelessness to action in Ethiopia: the significance of the Seqota Declaration 

The domestic controversy over China’s foreign aid and the implications for Africa 

Measles is about more than a fever and a rash 

What Preventable Killer Disease is This Pharma Foundation Fighting in East Africa? 

Human Rights Reader 371 

MSF: Chiedi a Obama di consentire l’investigazione indipendente sul bombardamento dell’ospedale di Kunduz 

Aid panel wants probe of deadly US airstrike in Kunduz 

RAPID ASSESSMENT OF HEALTH SERVICES IN EASTERN AND SOUTH-EASTERN ANATOLIA REGIONS IN THE PERIOD OF CONFLICT STARTING FROM 20 JULY 2015 

Breaking News: Link 161

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

medusa

Breaking News: Link 161

 

WHO: Public Health Round-Up 

After Trans-Pacific Partnership Deal Reached in Atlanta, Focus Shifts to Ratification 

TPP deal: US and 11 other countries reach landmark Pacific trade pact 

Summary of the Trans-Pacific Partnership Agreement 

Pull Up Your Socks – The TPP Is Done 

What does the TPP deal mean for outsiders?  

NEW YORK Global Dev Week 2015 

Good news: Global health is actually improving. Huzzah, civilization! 

October 11-13, 2015 World Health Summit Berlin, Germany 

5th BRICS HEALTH MINISTERS’ MEETING Moscow, the Russian Federation, October 30, 2015 

QUALE FUTURO PER I FARMACI INNOVATIVI IN ITALIA? Mercoledì, 4 novembre 2015 Roma  

Save the date: Improving price transparency for vaccines: What can the EU do? European Parliament October 21st, 10-12.30 Room A5G1 

Are the U.N. Sustainable Development Goals Doomed? 

Ensuring That the Sustainable Development Goals Are Not a Missed Opportunity 

Missed Opportunities in Global Health: Identifying New Strategies to Improve Mental Health in LMICs 

The UN’s Sustainable Development Goals: Global Schizophrenia 

The SGD Summit in New York: Being part of history and lovin’it! 

IMF’s Managing Director Christine Lagarde on how to implement the Sustainable Development Goals 

Cap-And-Trade, Green Climate Fund Are Fraught With Fraud 

European Environment Agency: Corporate Design Manual 

IMF Chief: We’re cooked if we fail on climate change 

New UN treatment guidelines say all people with HIV should get antiretrovirals 

The Medicines Patent Pool Statement on World Health Organization New HIV “Treat-All” Recommendation  

Can new drug stop HIV among gay men? 

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 

With new hope on the horizon, now is the time to invest in women and HIV  

Drugs for Neglected Diseases initiative Unveils New Plan for Neglected Patients 

Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted 

Evaluating the quality and use of economic data in decisions about essential medicines 

A Glitch In The Road To Pay-For-Performance 

ACA Progress, Health And Social Supports 

Measuring What Matters In Primary Care 

What State Policies Best Foster Insurance Market Competition? 

Profile: Cipla’s Hamied On Cambridge, O-Levels And Sticking It out 

Cooperazione Italiana allo Sviluppo: Diretta streaming dell’evento “Protezione sociale e il ruolo delle donne per nutrire il Pianeta” 

 

Farmaci Contraffatti: Una Piaga Africana

Ogni anno, circa 800.000 persone muoiono nel mondo per aver utilizzato farmaci contraffatti. Molte di queste vittime sono Africani. A causa di governi corrotti, un tessuto sociale instabile e una povertà dilagante, queste persone sono sempre più frequentemente preda di questo mercato. Purtroppo, il fenomeno è sempre più in espansione a causa di una debole volontà politica e di forti interessi contrastanti

Pietro_picture-150x150

by Pietro Dionisio

Degree in Political Science, International Relations

Cesare Alfieri School, University of Florence, Italy

FARMACI CONTRAFFATTI: UNA PIAGA AFRICANA

 

Sono molti i problemi che affliggono il continente Africano. Fra questi possiamo annoverare quello dei farmaci contraffatti.

Seguendo la definizione che ne da l’OMS, possiamo affermare che un medicinale falso è quello “la cui identità e/o origine, fraudolentemente e deliberatamente, è dichiarata in modo erroneo. La contraffazione può essere applicata sia a prodotti di marca, sia a quelli generici. In aggiunta, sono da considerarsi medicinali falsi quelli i cui principi attivi sono sbagliati, completamente assenti o in quantità non sufficiente. A questi vanno sommati i farmaci il cui imballaggio è falso”.

Questo fenomeno è in forte espansione nel continente e i principali paesi che esportano tali prodotti sono Cina ed India. Si ritiene che solo nel 2009, 45 milioni di farmaci antimalarici ( pari ad un valore di $438 milioni) siano stati commercializzati da questi due Paesi verso l’Africa dell’Ovest. Ma il problema è ingigantito anche dal fatto che gli stessi Africani producono farmaci di nulla o bassa qualità. Non è difficile trovare venditori abusivi che agli angoli delle strade vendono farmaci contraffatti a basso costo, attirando così i più poveri. Se a questo aggiungiamo una corruzione elevata e conflitti d’interesse nelle alte sfere governative, ecco che il problema può solo assumere dimensioni macroscopiche.

Tale stato di cose potrebbe essere in parte ridotto se fosse applicata concretamente una efficiente normativa e una susseguente sua implementazione, se la legislazione attuale non presentasse dei punti deboli e se le sanzioni e le pene applicate fossero più incisive così da costituire un deterrente.

Lev Tolstoj affermava che “il denaro è la schiavitù moderna”. Tale affermazione non può che essere adeguata al contesto qui trattato. Infatti, la situazione attuale evidenzia che il giro di soldi intorno a tale mercato rende ogni azione finalizzata a contrastarlo sostanzialmente poco utile. Ne sono dimostrazione di questo le stime per il futuro che parlano di un aumento previsto della produzione di medicinali falsi pari al  20%.

Tali prodotti, spesso, contengono mercurio, alluminio, piombo, uranio, arsenico, cadmio, selenio e cromo. Queste sostanze, oltre a causare seri problemi per la salute dei pazienti (ogni anno circa 800.000 persone, molte delle quali in Africa, muoiono a causa di medicine contraffatte), possono anche indurre il formarsi di fenomeni di resistenza data l’assenza del giusto principio attivo nel farmaco.

Le dimensioni del problema sono tali da richiedere una sua risoluzione quanto mai rapida. Come già accennato poco prima, la questione è estremamente critica, e dati gli interessi che ruotano attorno a questo tipo di mercato diventa difficile ipotizzarne un completo epilogo. Sicuramente, una campagna educativa sui danni che tali farmaci possono causare, mirata non solo ai pazienti, ma anche agli organi governativi e agli stessi venditori abusivi, potrebbe quantomeno ridurre le proporzioni di tale fenomeno. Conviene ribadire come una classe governativa più conscia degli effetti negativi di tali “medicine” potrebbe portare avanti un processo legislativo atto a rallentare l’espandersi di queste produzioni così come  la certezza di incorrere in pene adeguate alla colpa potrebbe essere un ulteriore strumento utile a tale scopo.

In assoluto, sia il mezzo legislativo che quello educativo possono essere degli ottimi metodi per raggiungere l’obbiettivo. A questi, sicuramente, è da aggiungere lo strumento tecnologico. Siamo nell’era del 2.0 applicato anche al settore sanitario.

A tale riguardo, è di notevole interesse la notizia secondo la quale un imprenditore del Ghana ha inventato una applicazione per cellulare la cui funzione è quella di individuare farmaci contraffatti. La compagnia che gestisce tale applicazione è la MPedigree. Quest’ultima vende i software che i produttori utilizzano per etichettare le singole confezioni di farmaci con un codice casuale composto da 12 cifre nascosto sotto un riquadro da grattare sulla confezione. Quando una persona acquista il medicinale, può digitare tale codice a MPedigree gratuitamente, così da ottenere in tempi molto brevi una risposta contenente l’informazione relativa all’autenticità del farmaco.

Ogni questione, sia a livello nazionale che internazionale, per potere progredire e migliorare necessita del sostegno di una volontà politica forte e determinata. Nel momento in cui tale volontà , o è assente, o non è sufficientemente forte, ogni risultato raggiungibile diventa irraggiungibile. Questo è quanto stiamo toccando con mano in ambito di lotta ai farmaci contraffatti.

Le grandi industrie farmaceutiche potrebbero, forse, ridurre i loro i prezzi agevolando l’acquisto di medicine anche per i più poveri? Un dibattito questo notoriamente discusso e trattato da lungo tempo ma che, davvero, potrebbe rappresentare un primo, vero traguardo!

UN SDGs Need U-Turn on Governance for Health

Article republished from Intellectual Property Watch September 24, 2015 http://www.ip-watch.org/2015/09/24/un-sdgs-need-u-turn-on-governance-for-health/   

The 2030 Agenda for Sustainable Development, to be adopted this week at UN Headquarters, could fall short of its health targets unless the governments embark on “U-turn” changes to rectify the dysfunctions in global governance that undermine health

MINOLTA DIGITAL CAMERA

by Daniele Dionisio*

Policies for Equitable Access to Health – PEAH

UN SDGs Need U-Turn on Governance for Health

 

In today’s world landscape, which is torn by dis-alignment, litigations and frictions among the involved parties, the root causes of health inequities are to be found in weaknesses in political domains at the supranational level. As reported, these include: democratic deficit, weak accountability, institutional stickiness, missing institutions and restricted policy space for health.

This context entails that unbiased solutions for global health only hinge on political will to improve equity, coherence, coordination, collaboration, transparency and accountability both at domestic and international level.

Unfortunately, the current governments’ directions and trade agreements, largely by the European Union (EU) and the United States (US), run contrary to these principles while turning intellectual property (IP) agendas into policies which protect monopolistic interests at the expense of equitable access to care and lifesaving treatments in resource-limited settings.

In this connection, since the incentives of the current patent system are driven by profits, where short-term maximization of returns to shareholders is prioritized, the lower-income countries lacking profitable pharmaceutical markets are all the more discriminated.

Overall, this represents the failure of the current policies for global health as featured, just for example, by the mismanaged containment of current Ebola epidemic.

Meanwhile a 2030 Agenda for Sustainable Development is to be adopted this week at UN Headquarters. The Agenda consists of 17 Sustainable Development Goals (SDGs) and 169 targets that aim … to be a charter for people and the planet in the twenty-first century. They will stimulate action over the next 15 years in areas of critical importance towards building a more equitable and sustainable world for all.

As highlighted, …..In that scheme, the health goal ranks high as an overarching aim amidst the other 16 SDGs. It includes nine targets: three relating to MDGs, three to non-communicable diseases and injuries, and three cross-cutting or focusing on systems encompassing UHC, universal access to sexual and reproductive health care services, and also to reduced hazards from air, water and soil pollution.

Furthermore, the health goal strictly entwines with a number of the other 16 proposed goals. For example, health is a contributor to (and a beneficiary from) poverty reduction, hunger relief and improved nutrition, safer cities, lower inequality, sustainable consumption, affordable and clean energy, toxic chemicals management, clean water and sanitation, and to the efforts to combat climate change and safeguard aquatic and terrestrial ecosystems as well.

Relevantly, what expectations on the world landscape mentioned above? Hopes that comprehensive, non-discriminatory health goals could easily be reached are hardly credible with the load of unresolved issues still on the table. As argued…Achieving health equity is not just a matter of coming up with technical solutions and providing the means to finance them. We have to consider the political landscape and rectify the dysfunctions in global governance that undermine health…

Admittedly, governments in the most affluent countries look like they wouldn’t be ready to embark on these gaps as an opportunity to advance public health over political and commercial interests.

Call for Common Governance Agenda

As such, prospects for global health goals only depend on non-stop, multi-sector engagement worldwide to pressure governments into making “U-turn” changes by common measures on a shared agenda that include:

  • Rejecting pressures towards adopting heightened IPRs and strengthened enforcement mechanisms as the keys to foreign investments and innovation.Reportedly, …inclusive evidence typically shows that most low- and middle-income countries do not benefit economically from IP maximization since they are net importers of IP goods and since the path to technological development is ordinarily through copying and incremental innovation-development tools that are severely undermined by IP monopoly rights and their related restrictive licensing agreements…
  • Rejecting World Bank income classification to measure a country’s capacity to afford high-priced medicines. As argued, ...the World Bank classification dates back to the 1980s and only measures a country’s per-capita average of total income. However, the map of poverty has changed since the 1980s. Today, the majority of the world’s poor no longer live in poor countries, but rather in places where there is greater wealth along with higher inequality.

Relevantly, MSF recently contended that ….the US Medicaid-defined poverty line ($21.50/person per day) would be a far more reliable tool to estimate how many millions will live below it once countries cross the high-income threshold. As regards TPP countries, MSFalso highlighted that …In eight of the 12 TPP countries for which there is data, more than a quarter of a billion people will live below the US Medicaid line when their country is classified as high income. By the time Malaysia and Mexico reach high income designation, more than 80 percent of their populations will still fall below this poverty line. Among current high-income TPP countries, the percentage of the population under this poverty line ranges widely, going as high as 69 percent in Chile.

  • Rejecting privatization policies, including by publicly funded insurance packages using networks of private providers. As reported, ….while reinforcing the notion that healthcare is a commodity and not a basic human right, this approach, proposed by the World Bank and their allies, has several problems and side effects: fragmentation of care, higher cost, precedence of procedures over preventive medicine and further dismantling of the public healthcare system. At the same time, insurance packages divert attention and funds from a more comprehensive approach directed at modifying the root causes of disease, through socioeconomic interventions aimed at increasing equity.

Inherently, as per a report from the Philippines, …the current privatization policies of the Philippine government do not provide an answer to the enormous health needs. Despite the name of the Philippine “Universal Health Care” program that claims to “bring equity and access to critical health services to poor Philippinos”, commercialization of health services will do exactly the opposite. Unfortunately, the European Commission is supportive of these policies and formerly approved a contribution of euros 33 million in support of the Health Sector Reform Agenda of the Philippine government….

  • Rejecting closed doors negotiations since they blur transparency.
  • Banning the non-violation nullification of benefits (NV) clause under TRIPS.
  • Banning TRIPS-plus clauses, including investor state dispute settlement (ISDS) provisions, that could negatively affect health and worsen inequalities in access to care and treatments.
  • Withdrawing pressures on LMICs to jeopardize the use of TRIPS safeguards and flexibilities relevant to the price of medicines.
  • Pushing for open knowledge and new approaches to pharmaceutical innovation that do not rely on the patent system and de-link the costs of R&D from the price of medicines.
  • Promoting technology transfer with least-developed countries without exporting excessive IP standards through assistance programs.
  • Backing generic competition as the most effective way to lower medicine prices in a sustainable way.
  • Backing governments that make use of TRIPS safeguards and flexibilities to protect and promote public health.
  • Linking together patent offices and legislators worldwide to develop evidence-based reforms of the patent regime of medicines. As contended, …[I]f countries set higher standards for incremental innovation patenting, and permit citizen or third-party review of patents before and after examination, then we will likely see increased generic competition in the …..market, new combination therapies, and lower … prices. In the longer term, higher inventiveness standards will help clear the patent thicket to allow new products to develop, and push industry towards genuine innovations….
  • Actively supporting partnership agendas (as per DNDI and GAVI examples among others) that are devoted to the development of new medicines and vaccines for neglected diseases that disproportionately affect poor population settings.
  • Ensuring that the Global Fund to Fight AIDS, Tuberculosis and Malaria continuesto use generic medicines and support UNITAID work to make quality medicines and diagnostics available and affordable.
  • Ensuring that revenues from a Financial Transaction Tax (FTT), whose approval isin slow progress in Europe, will be substantially committed to development and for the fight against health scourges, diseases of the poor and pandemics. FTT revenues would be a resource for the EU to channel towards the WHO and Global Fund needs. An FTT would be instrumental to the spirit and resolutions of latest WHO Assemblies. Hence, it should be up to the EU to push that non-discriminatory access to health and lifesaving medicines becomes a substantial objective for FTT revenues.
  • Ensuring that leading institutions and organizations enhance working with health ministries to strengthen national systems, invest in infrastructures, improve transparency and accountability, and boost needs-driven rather than market-driven rules. This would mean giving up “closed doors”€negotiations and adopting multi-sector participatory models for decisions affecting national health, growth, employment and budgets.
  • Ensuring that international agreements include clauses whereby donors must strengthen WHO-aligned quality clauses in tender transactions with non-governmental organizations, while purchasers must insist that manufacturers and distributors supply medicines that meet WHO requirements, and governments must authorize export only of products meeting WHO quality, efficacy and safety standards.
  • Ensuring that research and innovation for health is linked to improving economic prosperity and is critical to eradicating poverty, since poor health and disability contribute substantially to poverty.
  • Ensuring that indicators for R&D for health tools that primarily affect LMICs address a comprehensive set of outcomes including financing, infrastructure and human resources needs, enabling policies, necessary partnerships, capacity strengthening, and access requirements.
  • Ensuring that any research and innovation indicators measuring progress against the goals and targets outlined in the post-2015 agendaalso increase accountability of researchers, governments, and funders, and inform research processes. Ultimately, the success or failure of the post-2015 agenda relies just as much on how the goals and targets are implemented as it does on how progress will be measured. In support of the inclusion of research and innovation for health in the post-2015 agenda, over 150 organizations and individuals last year signed a petitionto Secretary General Ban Ki-Moon and Member States urging the UN to keep the research, development, and delivery of new and improved health tools for diseases and conditions impacting LMICs at the heart of the post-2015 development agenda.
  • Seeking synergies among global level institutions to address global health challenges, support stronger leadership by the WHO to improve global health, enhance dialogue and joint action with key players, including UN agencies involved in global health, international financing institutions, regional organizations, regional health networks, and countries, in order to coordinate actions, advance in the achievement of commitments, and avoid overlapping and fragmentation.
  • Seeking synergies for equitable health access with fast growing, including BRICS and N-11, middle-income country economies.
  • Pushing for more complementaryrelations among World Bank, IMF, ADB, AFDB, AIIB and the BRICS Development Bank as regards the development and health needs of marginalized population settings in LMICs.
  • Pushing for full exemption of out-of-pocket expenses for the poor; poor-friendly pathways towards universal health coverage; heavy taxation on tobacco and other harmful substances; and reduction or elimination of agricultural export subsidies and energy subsidies on air-polluting fuels.
  • Opposing land grabbing, deforestation and state-managed food reserve dismantling policies.
  • Reversing “brain drain”, health worker shortage by a transformation of the present training approach, as to adapt curricula to local needs, promote strategies to retain expert faculty staff, expose trainees to community needs during training, promote multi-sector approach to education reforms, and strengthen links between the educational and health care delivery system. Western academic institutions’ role is to facilitate the process.
  • Asking for the European Medicines Agency (EMA) to be financed only throughEU budget as per application fees channeled to the European Commission. This would improve transparency and accountability.
  • Asking for anti-counterfeit laws and law enforcement policies not to substitute for effective national regulatory frameworks.
  • Asking for organizations with potential conflicts of interests and IP perspectives to issue statements eschewing the use of IP law to counter generic medicines.
  • Asking for investment in technologies to detect “bad medicines”to be followed upwith provisions to increase public awareness and incident reporting, along with regulations on medicine quality that include definitions as per shared WHO terms.

—————————————————————————————-

*Daniele Dionisio is a member of the European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases. He is an advisor for “Medicines for the Developing Countries” for the Italian Society for Infectious and Tropical Diseases (SIMIT), and former director of the Infectious Disease Division at the Pistoia City Hospital (Italy). Dionisio is Head of the research project PEAH – Policies for Equitable Access to Health. He may be reached at d.dionisio@tiscali.it http://www.peah.it/ https://twitter.com/DanieleDionisio

Breaking News: Link 160

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

medusa

Breaking News: Link 160

 

EU Council Parliamentary Assembly: Public health and the interests of the pharmaceutical industry: how to guarantee the primacy of public health interests? (text adopted on 29 September 2015) 

Live from New York, it’s Global Dev Week 

UN SDGs Need U-Turn On Governance For Health 

Say goodbye to capitalism: welcome to the Republic of Wellbeing 

An Ambitious Development Agenda From the U.N. 

SDGs: A doorway to substantial change for people with disabilities?  

The missing SDG indicators: Accelerating gender equality and empowerment

Sustainable development goals promise little respite for indebted poor countries 

What the U.N.’s New Development Goals Mean for Africa 

The UN’s development goals require another step first: universal healthcare 

What, Really, Does ‘Sustainable’ Mean? 

FACT SHEET: U.S. Global Development Policy and Agenda 2030 

White House declares truce with China over AIIB 

China-U.S. deal sets bar low ahead of Paris climate talks 

Climate Change Is So Bad That the US and China Agree on It 

Dear Climate Funders: The Clock is Ticking. Use Your Endowments 

The Importance of Global Health Investment 

Human Rights Reader 370 

HEALTH SYSTEMS through CONFLICT AND RECOVERY 4-15 April 2016 Pisa, Italy 

Can Big Data Help Government Do Better? This Foundation Thinks So 

TTIP Could Lead To Jobs, Access To Better Drugs, Says Pharma 

TPP trade pact will deepen global crisis of exorbitant drug prices unless dangerous terms are removed 

Industry Holds Closed-Door Conference With Governments On Access And Benefit-Sharing  

Today’s nutrition work calls for business, tech skills 

The Global Migration Crisis, International Law, And The Responsibility To Protect Health 

The dilemma in Controlling the Contact between Humans and Live Poultry: Lessons from a Re-emerging Human H7N9 Influenza Case in Shanghai China

Since the first H7N9 influenza case was diagnosed in 2013, the disease has involved more than ten provinces and municipalities of China. There are a number of cases diagnosed in the years 2014 and 2015, most of whom had a history of live poultry contact, although there are already strict limitations on the purchase of live poultry. This reflects the dilemma between the needs of disease prevention and pre-existing social economic factors. Here we discuss this issue starting from a recent case of human H7N9 influenza diagnosed in Shanghai

The dilemma in Controlling the Contact between Humans and Live Poultry

Lessons from a Re-emerging Human H7N9 Influenza Case in Shanghai China

  Hongzhou-Lu

By Hongzhou Lu*

and Tangkai Qi, Jiaying Shen

Division of Infectious Disease

Shanghai Public Health Clinical Centre affiliated to Fudan University

 

The Case

A 52 years old man in Shanghai bought live chicken and slaughtered it at home on March 23rd , 2015. 3 days later he started to have a fever of 38.6 oC accompanied with chills. He had neither respiratory symptom, gastrointestinal symptom nor other discomforts. He took antipyretic drug by himself and fever relieved. On March 27th the body temperature went as high as 39 oC. Chest X-ray at a local hospital showed “Increased veins of bilateral lung”. The doctor considered “viral upper respiratory infection” and prescribed non-steroidal anti-inflammatory drug. On April 1st the patient had a fever as high as 39.6 oC accompanied with nonproductive cough. So he went to the District Central Hospital. Chest CT scan showed “inflammation on the lower lobes of both lungs”. A rapid swab antigen test showed a positive result of influenza A. He was given a combined therapy of oseltamivir phosphate at 150mg twice daily), levofloxacin 400mg per day, imipenem cilastatin 2g per day, methylprednisolone 40mg per day, human immunoglobulin 20g per day, as well as symptomatic treatment. The patient’s condition deteriorated and developed breath shortness on April 5th. A repeated chest CT also showed more severe lung foci. Throat swab was collected and sent to local CDC on April 5th. On April 6th, there was a positive H7N9 PCR report. The patient was confirmed with a diagnosis of human H7N9 avian influenza and transferred to our hospital. He was continued with oseltamivir 150mg twice daily treatment for 7 days and discharged on April 15th.

Discussion

There is an established link between human H7N9 influenza and contact with live poultry markets [1,2]. Soon after the outbreak of human H7N9 influenza, the Shanghai municipal government totally suspended live poultry trade according to the advices from experts [3,4]. Other cities also took similar measures wherever human cases were reported. Surveys estimated that closure of live poultry markets (LPMs) reduced the daily number of human infections by 97-99%, respectively [5,6]. These policies were extended in the epidemic seasons of the years 2014 and 2015. In non-epidemic seasons, live poultry trade was permitted only in isolated regions of designated markets, with close monitoring on the birds and environment.

The Shanghai municipal fully suspended live poultry purchase from February 19th to April 30th, 2015. However this patient developed flu like symptoms three days after contact with live poultry on March 23rd. Then we learned that he bought it from Taicang city near Shanghai, where live poultry trade has also been suspended. It turned out that the patient traded with an unlicensed individual trader nearby a market at Taicang. This reflects a long lasting dilemma between the needs of infectious diseases prevention and social economic needs.

Certain factors might have contributed to this dilemma:

  • Dietary needs and cultural habits: chefs and home cooks have become accustomed to buying live birds, slaughter it and prepare dishes which fit people’s tastes. This demand is even more robust during traditional festivals.
  • Economic benefits: Human H7N9 avian influenza outbreaks lead to a direct economic loss of over 6.5 billion US dollars within 3 months, estimated by the Chinese Ministry of Agriculture. Accompanied is the shutdown or bankruptcy of enterprises that keep or purchase live poultry. Even though live poultry markets are shut down, dietary and livelihood needs drive people to purchase live poultry beyond the monitoring.
  • Part of the H7N9 influenza patients had a history of keeping domestic poultry instead of contacting with live poultry market. Despite of the progress of urbanization, there are a large number of people staying in rural areas, maintaining self-sufficient rural economy including backyard poultry. Household of poultry is deeply rooted in the local farming culture and daily life, posing additional challenge to restrict the contact between human and poultry.

At the same time, a number of different subtypes of avian influenza viruses is emerging in live poultry markets, some of which have resulted in human disease (Table 1). It is necessary and urgent to control the spread of avian influenza virus from birds to humans in a vast and populated country like China, so that to better protect the health of the people and prevent endemic or pandemic influenza. To better manage the production and trading of live poultry, several measures might be considered including:

  • Periodic public hearing involving animal scientist, infectious disease specialists, epidemiologists, poultry enterprises, customers and policy makers. So that they can develop strategies taking into account both the needs of public health and concerns of private stakeholders.
  • More public advertisement about the knowledge of infectious disease prevention and control, especially that about H7N9 influenza. Given H7N9 avian influenza predominantly occurs in middle-aged and old people, special efforts should be made to educating this population.
  • Fast development of avian H7N9 influenza vaccine (to be provided for free or low-cost to poultry farms and housekeepers).
  • Economic compensation to encourage family farmers stop poultry keeping, together with employment support to live poultry salesmen after closing LPMs.
  • Legislation and law enforcement in guaranteeing the security of public health. Joint power of law and human emotion will guide the public to establish a healthy and safe lifestyle.

Table 1 Avian influenza in human and marketed birds academically reported from 2011 to 2015

Subtype Year Country Avian infection Human infection Citation
H11N2 2012 China Yes No [7]
H4N2 2012 China Yes No [8]
H3N2 2012 China Yes No [9]
H10N9 2013 China Yes No [10]
H7N9 2013-2015 China Yes Yes [4]
H5N2 2012-2013 Vietnam, Nigeria Yes No [11][12]
H6N1 2013 Taiwan No Yes [13]
H5N6 2013 China Yes No [14]
H4N6,H4N9 2014 Thailand Yes No [15]
H10N8 2014 China Yes Yes [16]

 

References

  1. Bao CJ, Cui LBZhou MH, et al. Live-animal markets and influenza A (H7N9) virus infection. N Engl J Med. 2013 Jun 13;368(24):2337-9. doi: 10.1056/NEJMc1306100.
  2. Wu P, Jiang H, Wu JT,et al. Poultry market closures and human infection with influenza A(H7N9) virus, China, 2013-14. Emerg Infect Dis. 2014 Nov;20(11):1891-4. doi: 10.3201/eid2011.140556.
  3. Lee SS, Wong NS, Leung CC. Exposure to avian influenza H7N9 in farms and wet markets. Lancet.2013 May 25;381(9880):1815. doi: 10.1016/S0140-6736(13)60949-6.
  4. Xu J, Lu S, Wang H, Chen C. Lancet. 2013 May 25;381(9880):1815-6. doi: 10.1016/S0140-6736(13)60950-2.
  5. He Y, Liu P, Tang S, et al. Live poultry market closure and control of avian influenza A(H7N9), Shanghai, China. Emerg Infect Dis. 2014 Sep;20(9):1565-6. doi: 10.3201/eid2009.131243.
  6. Yu Chen, Weifeng Liang, Kwok-Yung Yuen et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. The Lancet, 25 April 2013; doi:10.1016/S0140-6736(13)60903-4.
  7. Zhang Y, Teng Q, Ren C, et al. Complete genome sequence of a novel reassortant H11N2 avian influenza virus isolated from a live poultry market in eastern China. J Virol. 2012 Nov;86(22):12443. doi: 10.1128/JVI.02236-12.
  8. Teng Q, Ji X, Li G, et al. Complete genome sequences of a novel reassortant H4N2 avian influenza virus isolated from a live poultry marketin eastern China. J Virol. 2012 Nov;86(21):11952. doi: 10.1128/JVI.02179-12.
  9. Teng Q, Hu T, Li X, et al. Complete genome sequence of an H3N2 avian influenza virus isolated from a live poultry market in eastern China. J Virol. 2012 Nov;86(21):11944. doi: 10.1128/JVI.02082-12.
  10. Su C, Chen S, Liu X, et al. Genome Sequence of a Novel H10N9 Avian Influenza Virus Isolated from Chickens in a Live PoultryMarket in Eastern China. Genome Announc. 2013 Jun 27;1(4).pii: e00386-13.doi: 10.1128/genomeA.00386-13.
  11. Nishi T, Okamatsu M, Sakurai K, et al. Genetic analysis of an H5N2 highly pathogenic avian influenza virus isolated from a chicken in a live bird market in Northern Vietnam in 2012. J Vet Med Sci. 2014 Jan;76(1):85-7. Epub 2013 Aug 27.
  12. Coker T, Meseko C, Odaibo G, et al. Circulation of the low pathogenic avian influenza subtype H5N2 virus in ducks at a live bird marketin Ibadan, Nigeria. Infect Dis Poverty. 2014 Nov 3;3(1):38. doi: 10.1186/2049-9957-3-38. eCollection 2014.
  13. Wei SH, Yang JR, Wu HS,et al. Human infection with avian influenza AH6N1 virus: an epidemiological analysis. Lancet Respir Med.2013 Dec;1(10):771-8. doi: 10.1016/S2213-2600(13)70221-2. Epub 2013 Nov 14.
  14. 14.Qi X, Cui L, Yu H, Ge Y, et al. Whole-Genome Sequence of a Reassortant H5N6 Avian Influenza Virus Isolated from a Live PoultryMarket in China, 2013. Genome Announc. 2014 Sep 11;2(5). pii: e00706-14. doi: 10.1128/genomeA.00706-14.
  15. Wisedchanwet T, Wongphatcharachai M, Boonyapisitsopa S, et al. Genetic characterization of avian influenza subtype H4N6 and H4N9 from live bird market, Thailand. Virol J. 2011 Mar 21;8:131. doi: 10.1186/1743-422X-8-131.
  16. Zhang T, Bi Y, Tian H, et al. Human infection with influenza virus A(H10N8) from live poultry markets, China, 2014. Emerg Infect Dis. 2014 Dec;20(12):2076-9. doi:10.3201/eid2012.140911

———————————————————————————————-

* Correspondence to Dr. Hongzhou Lu luhongzhou@fudan.edu.cn

Funding: the grant of the 12th  Five-year Plan of China (grant 2012ZX10001003)

 

Waste – a Growing Global Health Threat

Health threats from waste thrive on socio-economic inequalities in two complementary ways: while affluence in parts of the global population produces mass consumption and rapid discarding of products (i.e. waste), poverty in another part invites the concentration and uncontrolled dumping of waste which amplifies its dangers to health...On a global scale, this transfer of waste from rich to poor unfolds when high-income countries export part of their hazardous waste to Africa and Asia

Waste – a Growing Global Health Threat

Iris-Borowy

by Iris Borowy

Institute for the History, Theory and Ethics of Medicine, RWTH Aachen University, Germany

 

Many years ago I spent a summer vacation in a small village in Poland. The landscape was beautiful, the people were friendly, and I enjoyed taking my infant son out for walks. However, I soon realized one problem: there was no regular garbage removal, as there was in my native city in Germany, and I did not know where to leave my son’s diapers. Helplessly and with a very bad conscience I eventually left them on the garbage heap behind the house, where they may still be visible today, as my son is getting ready to finish his Master’s degree. For all I know, they may have begun to disintegrate and to leak their mixture of organic and chemical contents into the heap, its surrounding soil, flushed away by rains, the bits blown away by winds. It was a perfect manifestation of overlapping layers of how we deal with waste: the problem of health-hazardous organic waste solved by the creation of synthetic waste, whose disposal visibly created a – potentially health-hazardous – problem which I could not ignore as usual since, in the absence of regular removals to some official dump, it remained in sight. I cannot claim innocence in the clumsy ways in which humanity is trying to deal with its ever growing production of waste material.

Organic Waste

For most of human history, the primary form of waste was organic, mainly human and animal faeces. It was a major source of new health risks when groups of early humans became sedentary, replacing hunting and gathering with agriculture, and, on a global scale, it has remained a major health risk since. The scale of the problem is truly impressive. According to the WHO, 2.5 billion people do not have basic sanitation facilities, at least ten percent of the global population is estimated to consume food irrigated by wastewater and some 946 million people, 13% of the global population, are forced to defecate in the open. Poor sanitation, exposing people to human organic waste, is estimated to cause 280 000 diarrhoeal deaths per year and to contribute significantly to malnutrition, cholera, dysentery, hepatitis A, typhoid, polio and other diseases. Overall, unsafe sanitation is estimated to have caused over 800,000 deaths in 2013.

At the beginning of the twenty-first century, these numbers are upsetting. The only good news is that they are also improving. Expanding access to sanitation has been one of the Millennium Development Goals, and though the target to half, between 1990 and 2015, the proportion of the population without sustainable access to basic sanitation has been missed by almost 700 million people, progress has been substantial: between 1990 and 2015, the proportion of people with access to improved sanitation rose from 54% to 68%, corresponding to 2.1 billion people. According to the 2013 Global Burden of Disease Study, deaths due to unsafe sanitation had fallen by more than half since 1990. And efforts continue on a high scale. Also in 2013, a UN resolution calling for Sanitation for All was followed by a global campaign to end open defecation.

While these developments certainly do not justify complacency, they can give some reason for optimism. At the same time, health threats from other forms of waste, though not – yet – on quite the same level, are increasing alarming.

Household waste is one of them. Municipal solid waste is a broad category. It includes products such as food, paper, glass, bottles, can, metals, packaging and other forms of plastics, clothes, batteries, electronic appliances (e-waste), paints, chemicals, light bulbs, spray cans, fertilizer containers, pesticides or medical waste. Some of these items, such as paints, pesticides or batteries, are easily hazardous to health because they include material which is toxic when ingested. Other items, such as electronics or batteries, are normally harmless and only become dangerous to health when degraded through burning or physical destruction, as frequently happens after disposal.

Estimates vary, but the amount of municipal waste is significant by any measure. In the European Union, where efforts to reduce waste have had some effect, total waste production nevertheless remains high, amounting to 2.5 billion tonnes in 2010, about a third of which was recycled, the rest was landfilled or burned. In terms of household waste, every person in Europe is currently producing half a tonne of waste per year. Approximately 98 million tonnes are categorized as hazardous, and despite tight official control, management processes can involve the generation of problematic substances including methane, carbon dioxide and other potentially toxic gases (like carbon or sulphur oxides), metals (like lead, cadmium, mercury, chromium, arsenic and beryllium) and organic compounds (like PCBs), which, individually and collectively, may have adverse health effects. Suspected problems include cancers, respiratory symptoms, irritation of the skin, nose and eyes, gastrointestinal problems, fatigue, headaches, psychological problems and allergies. But despite some well-established cases, the overall picture is still very unclear. Emissions from waste management processes tend to be mixtures of many substances for which a toxicological knowledge is incomplete.

The situation is far more serious in municipalities of the global South. Here, a lot of discarded products get reintroduced into the material stream through repair, recycling, charity and buy-back schemes. However, in the absence of controlled waste management, the overall amount and the management processes are particularly problematic. Every year, cities around the world produce seven to ten billion tonnes of urban waste, and three billion people worldwide, i.e. 40% of the world population, have no access to controlled waste disposal facilities. Given population growth, increasing urbanization and growing per capita consumption, especially in Asia and Africa, the United Nations Environment Programme (UNEP) expects the amount of global household waste to double within the next fifteen years. At present, a lot of global solid waste ends up in open dumpsites: informal land disposal sites with no or extremely limited measures to protect the surrounding environment, specifically without liners, leachate or gas management systems and without anti-flooding measures. A Waste Atlas, issued by the University of Leeds and several environmental associations in 2014, portrays the fifty biggest dumpsites in the world. Of this group, 24 sites contain hazardous waste, seven include e-waste and all are huge. The “typical” dump has been in operation for seventeen years, covers 24 hectars, harbors 2.5 million tonnes of mixed wastes, affects over 800,000 people living within a range of ten kilometers and is the place of work for 1,300 informal recyclers, people picking valuables out of the waste without any protective gear. Health risks result particularly from persistent organic pollutants (POPs) and toxic elements such as lead, mercury, cadmium or arsenic, frequently released through open burning of plastics and other waste in order to recover scrap. These toxic chemicals are inhaled, ingested through contaminated food or water and absorbed through the skin. The most common health effects involve gastrointestinal, dermatological, respiratory, and genetic systems and several types of infectious diseases. Waste pickers but also residents in the vicinity are at elevated risk of suffering from diarrhoea, pneumonia, chronic bronchitis, asthma, headaches, chest pains, irritation of the skin, nose and eyes, typhoid, stomach ulcers and many forms of cancer. Living close to a dumpsite also increases risks of low birth weight, preterm delivery and congenital malformations. On the basis of Waste Atlas estimates, these fifty dumpsites alone would expose some forty million people to these elevated risks. A more conservative study places a “mere“ 3.5 million people at risk from industrial and municipal dumpsites. It nevertheless comes to disconcerting conclusions since it assumes that exposure to lead alone from industrial and municipal dumpsites results in 1.2 million DALYs (Disability Adjusted Life Years) per year.

In addition, landfills are the third most important source of anthropogenic methane emissions and thereby contribute to climate change, which, in view of its manifold direct and indirect effects on health through droughts, floods, changes in agricultural output, disease patterns etc. has been called the biggest global health threat of the 21st century. Thereby, dumpsites contribute to health burdens which are just beginning to be felt, whose overall extent is impossible to gauge with any degree of reliability at present but which are sure to be substantial in the not too distant future.

Medical Waste

Ironically, even activities designed to enhance health contribute to waste and related health hazards. Hospitals and other medical institutions discard copious amounts of materials. Estimates about the amount of waste produced by US hospitals range from 2.1 to 4.8 million tons per year, about 20 % of which is plastic, often contaminated, always difficult to degrade. In 1996, the Environmental Protection Agency identified hospitals as an important source of dioxins in the USA. On a worldwide scale, data are similar: about 80% of waste from healthcare institutions can be characterized as general waste, 20% is considered hazardous material, which may be infectious, toxic or radioactive. Problematic waste includes material contaminated with blood or other body fluids, body parts, syringes, needles, chemicals (notably mercury, solvents and disinfectants), pharmaceuticals like expired, unusued or contaminated drugs, vaccines and sera or radioactive waste.

Pharmaceuticals have proved to be both particularly difficult to control and to have particularly disconcerting potential long-term effects. Prescription drugs such as antibiotics, painkillers and antidepressants find their way into sewer systems and rivers from hospitals, industry or private homeowners, either when improperly disposed or as partially metabolized pharmaceuticals from human excreta. One of their most worrying characteristic is their potential to act as endocrine disruptors. This risk also emanates from other forms of waste, such as dioxins and dioxin-like compounds, polychlorinated biphenyls which are found in many everyday products– including plastics, metal food cans, detergents, flame retardants, food, toys, cosmetics, and pesticides. Inevitably, they end up as waste on dumpsites.

Endocrine disruptors are chemicals that adversely affect the endocrine system of living beings, including humans, by mimicking hormones, influencing developmental, reproductive, neurological, and immune processes in both humans and wildlife. They have an impact on the genetic program of the fetus during gestation, so that effects may only become visible many years later, during adolescence or adulthood of the evolving adult human being. There is also growing evidence that endocrine disruptors might play a role in the development of chronic diseases, including hormone-related cancers, obesity, diabetes and cardiovascular disease, all rising concerns of the global burden of disease. Long considered a frivolous concern of the wealthy rather than a serious global health problem, this view is changing as the long-term potential of the threat is emerging. A 2012 WHO/UNEP report commented that chemical exposure in pregnancy may well affect the health of several subsequent generations of people and wildlife that are not themselves exposed.

This possible continuation of health effects far into the future makes the true significance of some forms of waste difficult to assess. This is true for its contribution to the health threats created by endocrine disruptors and climate change. It is spectacularly even truer for radioactive waste.

Radioactive Waste

Radioactive waste derives predominantly from nuclear power plants and, to a lesser extent, from military activities, medical practices and research, all producing a constant stream of hazardous radioactive waste. Despite the self-confident claim of the International Atomic Energy Agency that the world has over half a century’s experience in managing radioactive waste – the characteristics of the waste are well known and therefore it can be safely managed, the extreme length of persisting radioactivity makes the risk virtually impossible to either calculate or control. As Harold Feiveson and colleagues from the Atomic Scientists commented with perfect understatement: The safeguarding of a geological spent fuel repository would have to be of indefinite duration, but the means to ensure continuity of the responsible institutions and knowledge on time scales exceeding thousands of years is unknown. By 2010, 225,000 tonnes of spent fuel were being stored on a temporary basis around the world, mostly at existing nuclear power reactor sites. Finding safe final disposal sites has proved a difficult process in all countries concerned because of almost ubiquitous resident protest. Repositories for low-level radioactive material exist in most countries that use nuclear energy. To date, there is no permanent repository in the world for high-level radioactive waste.

Acute exposure to high-level radioactivity can be lethal. Chronic exposure to radioactivity, even at low levels, can result in a number of health problems including cancers, cataracts and potentially harmful genetic changes. However, given the highly varied forms of radioactive waste and the relevant time frames ranging from tens of thousands to millions of years, i.e. many times the length of all known human history, any estimate about future health risks is beyond even the wildest speculation.

Common Themes

At first sight it may seem that there is little that connects this hodge-podge of health threats except the shared name of “waste.“ Is it really more than a clever choice of words to lump the lack of toilets in Bangladesh together with the lack of permanent repositories for high-tech nuclear energy technology in Germany? This paper argues that these varied forms are, indeed, linked by several intertwined points.

First, all forms of waste reflect the increasing burden human activities are placing on global ecologies through a combination a rising population numbers and rising per capita waste production. In the process, all forms of waste reflect a mixture of necessity and choice. All people eat, defecate, use some form of energy and require a certain number of products to organize their lives for survival and comfort. All people and societies have some degree of choice about how they make use of material they need and how they discard the leftovers that are no longer needed or wanted. Generally speaking, the amount of – inherently problematic – waste can be expressed in an adapted version of the I=PAT equation by Paul Ehrlich, Barry Commoner and John Holdren: Waste is a product of population size, affluence and technology: W = PAT. Rising numbers of people, growing wealth and inadequate technology all contribute to a growing burden of waste. Collectively, they test the limits of absorption capacities of local and global ecologies, the object of controversy since the 1972 publication of the Limits to Growth. All forms of waste, therefore, form part of a large framework of environmental health, ultimately reflecting how people around the world are arranging their lives as part of large and small ecological systems.

Secondly, all forms of waste represent some degree of health threat, ranging from cholera to cancer and miscarriages. In all cases, the risk has been recognized and measures have been taken to meet it. The standard form of health protection in high-income countries focuses on waste disposing at a safe distance from people to be protected. This approach follows the example of sanitation procedures in Europe and North America, which, in many ways, provided a precedent for subsequent decisions regarding waste management. In the course of the nineteenth century, flush toilets were introduced in most cities, which improved sanitation in the cities at the expense of increasing the pollution of rivers and areas downstream. This choice of strategy was a break with traditional methods in farming societies, and it was not uncontroversial since it deprived agriculture of valuable nutrients. Scientists like Justus von Liebig warned that the nationwide installation of water closets would result in the loss of material sufficient to feed millions of people. But by the early twentieth century water-borne sewage had been broadly accepted and it had become a sign of modernity and civilization that faeces and urin could be flushed away and forgotten. Similarly, effective waste management was understood as an organized municipal waste removal service and the responsible disposal of all sorts of waste, at a safe distance from residential areas. Flushing waste down rivers, burning it in incinerators, storing it in landfills or burying it deep in the soil followed a similar rationale of making waste disappear – from the world or at least from sight.

The underlying concept has been that of a linear form of human (economic) activity in which all products eventually end up having to be discarded and which entails the production of useless and potentially harmful material. This approach has been a successful component of a development which has improved health levels and increased life expectancy in many countries. But it comes with serious weaknesses. On the one hand, in the closed system of planet Earth matter is transformed but does not disappear, and as the combined effects of a growing world population and increased per capita consumption have led and are continuing to lead to unprecedented levels of waste, making it disappear is becoming increasingly problematic. At the same time, this form of disposal literally wastes valuable resources in a way that is less and less affordable as the exploitation of finite and often scarce raw materials is not keeping pace with growing demand by more and more affluent people. If you will, treating matter as “waste“ entails a process of creating waste as much as of getting rid of it.

The alternative entails treating “waste“ as valuable material and resources to be reintegrated into further production processes. In the form of recycling, this concept is hardly new, but both in the interest of health and of economic stability (which also clearly affects health!) present recycling processes will have to reach a whole new level.

The idea to perceived human production and activities as part of a larger circular form of economic processes and physical transformation is quite old. It is the natural outlook of agricultural societies in constant need of organic fertilizer, i.e. societies of the overwhelming part of human history. For some years, it has been re-invoked under various names. In the 1990s, the chemist Michael Braungart and the architect William McDonough developed the idea of a cradle-to-cradle principle of production, aiming at a form of production that mimics natural processes, in which the end products of one cycle become the resources for the next cycle of production. In 1994, Gunther Pauli followed the same approach when he created the Zero Emissions Research and Initiatives at the United Nations University. A few years later, the idea advanced from pet projects of individual researchers to policy guidelines of important international organizations. In 1999, the OECD picked up on these issues for its own new program on Environmentally Sound Management of Waste (ESM). A year later, it advocated a „zero-waste“ model. In 2014, the European Environment Agency argued that well-being in Europe depended on a resource-efficient, circular economy and the European Commission similarly called for a shift from a linear to a circular economy. It also funds programs designed to produce a fundamental change of perspective that entails finding innovative ways of using waste as a resource.

This approach has been endorsed in other context as well. Scientists and activists, including the World Toilet Organization, point out the waste of energy and nutrients involved in a “flush-and-forget” attitude. Consequently, a toilet model spread in India by social entrepreneur Bindeshwar Pathak not only offers crucial hygienic safety and privacy but also allows the waste to biodegrade into fertilizer. Even the proponents of nuclear energy at the IAEA are beginning to see recycling of radioactive waste as a possible management strategy, and if only to increase public acceptance. Evidently, the assumption is that a visible solution of the problem of radioactive waste would increase public acceptance of nuclear energy. Logically, the conclusion could be that nuclear energy – or any other economic activity – should only be accepted when a realistic, non-hazardous method of reintroducing end-products into economic processes has been found.

Few actors go as far as making this demand, but a growing number call for a fundamental shift in our economic system from linear to a circular structures. While sounding attractive and intuitively right on paper, implementation is far from simple for many reasons, including technical and political. It is also challenging in psychological terms, because traditionally, large part of circular economic systems have been driven by poverty. People automatically reuse, repair and recycle when they cannot afford to discard and buy new products, and in many ways “flush-and-forget” and the ability to replace instead of repair have been experienced as positive developments of growing wealth. In ways that have a direct bearing on health, the relation to waste has been a function of inequality and of poverty and wealth.

Generally speaking, wealthy communities have been able to organize waste disposal in ways the less privileged have not. This is true for organic as well as for municipal and industrial waste and on a local as well as on a global scale. Thus, in a survey of 39 cities around the world, 96% of upper middle-class and 100% of upper class residents used controlled disposal methods but only 35% of lower class people. As a global equivalent, according to the Waste Atlas all but two of the 50 largest dumpsites worldwide are located in Asia, Africa, Latin America and the Caribbean, the two outliers being in Alushta (Ukraine) and Belgrade (Serbia). Even within high-income countries, landfills and incinerators are usually located close to residential areas of socio-economically disadvantaged populations and minority groups. Not only is waste and its burden on human health unevenly distributed at its source, it often flows from rich to poor, disadvantaging the poor even further. On a local scale, sewage from wealthy areas in low-income countries is frequently discharged into storm drains, waterways or landfills and thereby contributes to the pollution of residential areas of the poor. Similarly, the waste from affluent areas, removed out of sight of their residents, routinely ends literally in the hands of the poor who are forced to work as waste pickers. Thus, in low-income areas waste recovery and recycling are driven by scarcity, high prices for materials and the availability of workers who are sufficiently poor and desperate to work on dumpsites.

On a global scale, this transfer of waste from rich to poor unfolds when high-income countries export part of their hazardous waste to Africa and Asia. This happens either illegally or in the name of recycling, which, in countries with widespread poverty and corruption, often means little more than disposal on open dumpsites, ready to poison the lives of people working on and near the place. Though the export of hazardous waste has officially been regulated and restricted by the Basel Convention (1989) and banned by the Bamako Convention (1991), such material regularly finds its way from Europe to Africa, especially with regard to discarded electronics such as mobile phones or outdated computer screens.

Overall, health threats from waste thrive on socio-economic inequalities in two complementary ways: while affluence in parts of the global population produces mass consumption and rapid discarding of products (i.e. waste), poverty in another part invites the concentration and uncontrolled dumping of waste which amplifies its dangers to health. At the same time, the possibility of disposal out of sight of where products are used and discarded allows the illusion of a quasi waste-free world, or at least a world in which waste is no problem. In simple terms: the affluent produce a lot of waste and, in addition to modern technology, it is the less privileged who are preventing them from having to face its consequences.

Would the Polish village have had a regular removal service if more residents had been wealthy, had produced larger amounts and more non-degradable forms of waste such as throw-away diapers? And would I have found a different solution if it had been my back yard?

Conclusions

Human activities have always produced some sort of waste, and frequently waste has come with health risks. This problem, therefore, is not new, but its scale is. Never before in human history have people produced so much that was not re-integrated into some type of production process again. And never before have people produced so much matter that presents a tangible health hazard for present as well as for future generations. It is a challenge of serious proportions which humanity has hardly begun facing. It is also a challenge that goes to the heart of the existing global developmental system: if socio-economic wellbeing, including health-related wellbeing, is based on a system that produces health hazards on a rising scale, this system is inefficient, at best, and potentially catastrophic at worst.

Addressing the problem will require shifting towards a circular form of economy and mitigating local and global inequality, two strategies which seem easy in theory but daunting in practice. Both will require fundamental social, economic and cultural changes, letting go off beliefs and perspectives to which we have become accustomed. One concerns the way we see the world, a shift that Kenneth Boulding described fifty years ago with his demand to shift from a cowboy to an astronaut economy, i.e. from a world with lots of empty space and ample resources to a world where a limited amount of material had to be continually reused. Another change pertains to definitions of “development,” where it is headed and how its levels serve to categorize different parts of the world. Clearly, when it comes to waste management, neither the policy of “developed” countries to produce a lot of waste, including forms with long-term risk potential, nor the policy of “developing” countries to leave uncontrolled management practices to indigent waste pickers who ruin their health in the process, can serve as useful models. Instead, development must aim at policies that combine low- (ideally no-) waste procedures with high-level health protection policies and that shrink global economic inequalities.

 

Breaking News: Link 159

Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

medusa

Breaking News: Link 159

 

Your comprehensive guide to the UN’s Sustainable Development Goals summit 

Letter to the United Nations (UN) and its member states calling for the inclusion of indicators to measure global health research and development (R&D) in the Sustainable Development Goal (SDG) monitoring framework 

Charting a realistic course to attain SDGs 

Strengthening the Sustainable Development Goals (SDGs) 

7 steps toward sustainable development by 2030 

Without tackling substandard medicines, health goals will falter 

IMF’s Lagarde – weaker global growth complicates development goals 

Increased Domestic Resource Mobilization in Africa: A Priority for the Post-2015 Era  

Reflections on global economic governance at the “start of a new era”  

Health Advocates Press United States On WTO LDC IP Waiver 

KEI urges investigation of trade pressures on Least Developed Countries (LDCs) in light of Executive Order 13155 

US pharmaceutical company defends 5,000% price increase 

Exclusive: Americans overpaying hugely for cancer drugs – academic study  

Top US Lawmakers On Trade Urge Action On India’s Treatment Of IPRs 

Paper: Strict Plant Variety Protection In Africa Goes Beyond International Regulation 

Cultivating nutrition: Fortified crops and good nutrition in the first 1,000 days 

WHO bungling of Ebola crisis in Africa revealed in e-mails 

Malaria deaths cut by 60% since 2000 but UN says $6bn a year boost needed 

R&D plan announced for drugs for neglected diseases 

Launch of Regional Global Fund Grant to help fight TB in Eastern Europe and Central Asia  

PROGRESS AND ACHIEVEMENTS OF THE MEDICINES PATENT POOL 2010 – 2015 

Measuring poverty in a rapidly changing world 

Women should be at the heart of peacebuilding talks 

DOCUMENTI 2° CONFERENZA NAZIONALE SOSTENIBILITA’ E SALUTE 

DEBATE ON THE STATE OF THE EUROPEAN UNION 9 September 2015 

EMA organizza workshop sull’approccio da seguire per dimostrare il beneficio significativo dei nuovi farmaci orfani rispetto ai medicinali già esistenti 

Seven ways to get water on the climate agenda 

Is new Australian prime minister Malcolm Turnbull already a climate change turncoat? 

Air Pollution in China: Mapping of Concentrations and Sources